CHOPRA, S.; SHETTY, N.; GOEL, M.; ENGINEER, R.; RAJAMANICKAM, K.; KULKARNI, S.; POLNAYA, A.; PATKAR, S.; OSTWAL, V.; RAMADWAR, M.; SWAMIDAS, J.; PHURAILATPAM, R.; PAUL, S. N.; DHANDPANI, E.; JOSHI, K.; KANNAN, S.; RANGARAJAN, V.; MEHTA, S.; PATIL, P.; SHRIVASTAVA, S. K. Protocol for an integrated phase II/III randomised controlled trial of transarterial chemotherapy and sorafenib with or without stereotactic body radiation therapy in patients with nonmetastatic unresectable hepatocellular carcinoma. International Journal of Clinical Trials, [S. l.], v. 4, n. 1, p. 31–38, 2017. DOI: 10.18203/2349-3259.ijct20170306. Disponível em: https://www.ijclinicaltrials.com/index.php/ijct/article/view/161. Acesso em: 14 jun. 2025.